Communicates that since the advisory committee of growth hormone and related Substances have been updated âcriteria â andâ protocols â for the use of growth hormone.
The Criteria and protocols are available on the website of the ministry of health, Welfare and Consumption in section profesionales-farmacia:
As well as in the Web page of the Judicial General Mutuality
Since 1 July 2019 it should continue to these new âcriteria â as well as all applications for treatment in these protocols that are designed to be completed directly before printing.
The application of treatment to the advisory committee should be done by completing the protocols and start-up specified in the models attachments, that contain all parameters to assess underlying the criteria for authorization and renewal of treatment. Likewise, should be filed together with the boot protocol, informed consent from the patient duly filled out. The absence of completion of each and every one of the requested data can be the cause of a negative report to the start or continuity of growth hormone treatment .
- Application protocol treatment Start
- Monitoring protocol
- Informed consent